论文部分内容阅读
目的:探讨麻杏石甘汤加减联合西药治疗肺炎支原体肺炎患者的临床疗效。方法:选取84例肺炎支原体肺炎患者,随机分为观察组和对照组,对照组患者给予西药常规治疗,观察组患者给予麻杏石甘汤加减联合西药治疗,比较两组患者临床疗效、临床症状消失时间、住院时间及不良反应发生情况。结果:观察组患者临床疗效总有效率、显效率均显著高于对照组,差异均具有统计学意义(P<0.05)。观察组患者临床症状恢复时间和住院时间均短于对照组,差异均具有统计学意义(P<0.05)。观察组不良反应总发生率显著低于对照组,差异具有统计学意义(P<0.05)。结论:麻杏石甘汤加减联合西药治疗肺炎支原体肺炎患者可提高临床疗效,缩短临床症状消失时间及住院时间,从而减轻患者的经济负担,降低不良反应发生率,值得临床推广应用。
Objective: To investigate the clinical effect of “Maxing Shigan Decoction” combined with Western medicine in the treatment of Mycoplasma pneumoniae pneumonia patients. Methods: Eighty-four patients with Mycoplasma pneumoniae pneumonia were selected and randomly divided into observation group and control group. Patients in control group were given conventional western medicine. Observation group was given Maxing Shigan Decoction combined with western medicine. Clinical efficacy, clinical symptoms Disappear time, length of hospital stay and adverse reactions. Results: The total effective rate and markedly effective rate of clinical efficacy in the observation group were significantly higher than those in the control group, with statistical significance (P <0.05). The clinical symptoms recovery time and hospitalization time in the observation group were shorter than those in the control group, the difference was statistically significant (P <0.05). The total incidence of adverse reactions in the observation group was significantly lower than that in the control group, the difference was statistically significant (P <0.05). Conclusion: Maxing Shigan Decoction combined with Western medicine in patients with Mycoplasma pneumoniae pneumonia can improve clinical efficacy, shorten the disappearance of clinical symptoms and hospital stay, thereby reducing the financial burden on patients and reduce the incidence of adverse reactions, is worthy of clinical application.